NCT06512831View on ClinicalTrials.gov

Isoniazid Prophylaxis Based on Risk Factors of Tuberculosis in Living Kidney Transplantation Recipients

NACompletedINTERVENTIONAL

Enrollment

1,348

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

February 1, 2024

Study Completion Date

March 1, 2024

Conditions

Kidney TransplantationTuberculosisIsoniazid Toxicity

Interventions

DRUG

Isoniazid

Those with risk factors were recommended a 6-month prophylaxis regimen, consisting of INH (300 mg/d) and pyridoxine (10 mg/d to prevent INH-related neurotoxicity).

Trial Locations (1)

610041

West China Hospital, Sichuan University, Chengdu

All Listed Sponsors

lead

West China Hospital

OTHER

NCT06512831 - Isoniazid Prophylaxis Based on Risk Factors of Tuberculosis in Living Kidney Transplantation Recipients | Biotech Hunter | Biotech Hunter